Whenever there is life there are diseases, decay, and death. Death is the most inevitable biological event of a living system. Since life is the most precious gift of Nature, people want to preserve it as along as possible. In an endeavor to arrest the approach of death, our ancestors had not only to withstand the fury of Nature but also had to fight against diseases and decay. People were thus in search of remedial measures since the dawn of human intellect. The relationship of man and Nature was symbiotic and the immediate source of such remedial measures had been the forests, the home of our ancestors. They used to roam in and around the forests, and through thousands of years of interactions with Nature by trial and error methods, and under the pressure of experience and need they could discover a large number of plants with varying healing properties. These plants are referred to as the medicinal plants, and the people having the knowledge of their curative applications were known as medicine men. Thus a wealth of information on the curative properties of plants resulted.
- Antimalarial Activity
- Herbal Drug
- Sodium Salicylate
- Indole Alkaloid
- Pain Reliever
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
“I do not want to die in this beautiful world,
I want to live amongst the human beings.”
Rabindranath Tagore (1861–1941, NL 1913)
(translated from Bengali by the authors)
“No one wants to die. Even people who want to go to heaven don’t
want to die to get there. And yet death is the destination we all share.”
Steve Jobs (1955–2011)
(Convocation Speech at Stanford University on 12 June, 2005)
This is a preview of subscription content, access via your institution.
Tax calculation will be finalised at checkout
Purchases are for personal use onlyLearn about institutional subscriptions
P. Ray and H. N. Gupta, “Caraka Samhita (A Scientific Synopsis)”, Indian National Science Academy, New Delhi, 1965.
P. Ray, H. N. Gupta and Mira Ray, Susruta Samhita (A Scientific Synopsis)”, Indian National Science Academy, New Delhi, 1980.
Sukh Dev, Prime Ayurvevdic Plant Drugs – A Modern Scientific Appraisal, Ane Books Pvt. Ltd., New Delhi, 2012, 2nd Edition.
Koji Nakanishi, An Historical Perspective of Natural Products Chemistry in Comprehensive Natural Products Chemistry, Eds. Sir Derck Barton and Koji Nakanishi, Vol 2, 1999, pp XXI–XXXVIII.
Paluther (Artemether) Product Monograph, Rhöne-Paulene (India) Limited. This monograph with cited references was dedicated to the memory of Sir Ronald Ross when the world celebrated in 1997 the Centenary of the discovery (in 1897) of malaria parasite by him.
Wang Meng, Ren Xiaoliang, Gao Xiumel, Franco Francesco Vincieri and Anna Rita Bilia, Stability of Active Ingredients of Traditional Chinese Medicine (TCM), Nat. Prod. Commun., 2009, 4, 1761-1776.
Ginseng: The Elixir of Life, Korea Traveler (magazine of Tourism), 1987 (June/July), 16-18.
G. M. Cragg and D. J. Newman, Natural Product Sources of Drugs: Plants, Microbes, Marine Organisms, and Animals in Comprehensive Medicinal Chemistry, Vol 1, pp. 356-403.
Nitya Anad, Chairman’s Address: Herbal Drugs and Traditional Medicine: Perspective in the New Millennium, in Round Table Conference Series, No. 17, (25 March, 2006), Herbal Drugs – Perspectives in the New Millennium, Eds. S. S. Handa, C. K. Katiyar and O. P. Sood, Ranbaxy Science Foundation, New Delhi, India.
Sukh Dev, Ethnotherapeutics and Modern Drug Development: The Potential of Ayurveda, Current Science, 1997, 73, 909–928.
Sukh Dev, Proc. Indian Nat Sci. Acad., Sec. A, 1988, 54, 12
Sunil Kumar Talapatra, Some Useful Plant-Derived Drugs: Importance of Enantiomeric Stereospecificity, J. Indian Chem. Soc., 2003, 80, 731–743 Presidential address delivered at the 39th Annual Convention of Chemists, organized by the Indian Chemical Society at the Nagarjuna University, Nagarjunanagar, India, on December 23, 2002.
Jonathan L. Hartwell and Anthony W. Schrecker, Components of Podophyllum. V. The Constitution of Podophyllotoxin, J. Am. Chem. Soc., 1951, 73, 2909–2916.
Walter J. Gensler and Christos D. Gatsonis, Synthesis of Podophyllotoxin, J. Am. Chem. Soc., 1962, 84, 1748–1749.
L. S. Thurston, Y. Imakura, M. Haruna, De-Hua Li, Zong-Chao Lin, Su-Ying Lin, Yung-Chi-Cheng, and Kuo-Hsiung Lee, J. Med. Chem., 1989, 32, 604.
Petr Dzubak, Marian Hajduch, David Vydra, Alica Hustova, Miroslav Kvasnica, David Biedermann, Lenka Marcova, Milan Urban and Jan Sarek, Pharmacological Activities of Natural Triterpenoids and Therapeutic Implications, Nat. Prod. Rep., 2006, 23, 394–411.
Lisa S. Fernandez, Malcolm S. Buchanani, Anthony R. Carroll, Yun Jiang Feng, Ronald J. Quinn and Vicky M. Avery, Flinderoles A-C. Antimalarial Bis-indole Alkaloids from Flindersia species, Org. Lett., 2009, 11, 329–332.
Dattatraya H. Dethe, Rohan D Erande and Alok Ranjan, Biomimetic Total Syntheses of Filnderoles B and C, J. Am. Chem. Soc., 2011, 133, 2864–2867.
J. S. Glasby, Encyclopedia of Terpenoids, Wiley, New York, 1980, p. 1956.
Gautam Brahmachari, Natural Products in the Drug Discovery Programmes in Alzheimer’s: Impacts and Prospects, Asia Pacific Biotech. News, Singapore, 2011, 15,Sept. Issue, pp 26–38.
Z. Valenta, H. Yoshimura, E. F. Rogers, M. Ternbah, and K. Wiesner, The Structure of Selagine, Tetrahedron Lett., 1960, 26–33.
F. Yamada, A. P. Kozikowski, L. R. Reddy, Yuan-Ping Pang, J. H. Miller and M. Mckinney, A Route to Optically Pure (−)-Huperzine A : Molecular Modeling and in Vitro Pharmacology, J. Am. Chem. Soc., 1991, 113, 4695–4696.
Alan P. Kozikowski, Yan Xia, E. Rajaratham Reddy, Werner Tuckmantel, Israel Hanin and X. C. Tang, Synthesis of Huperzine A, Its Analogs, and Their Anticholinesterase Activity, J. Org. Chem., 1991, 56, 4636–4645.
Jia-Sen Liu, Yuan-Lang Zhu, Chao-Mei Yu, You-Zuo Zhou, Yan-Yi Han, Feng-Wu Wu, and Bao-Feng Qi, The Structures of Huperzine A and B, Two New Alkaloids Exhibiting Marked Anticholinesterase Activity, Can. J. Chem., 1986, 64, 837–839.
WHO Food Additive, WHO, Geneva, 1999 (on-line).
V. D. Patil, U. R. Nayak, and Sukh Dev, Chemistry of Ayurvedic Crude Drugs-I. Guggulu (Resin from Commiphora mukul)-1: Steroidal Constituents, Tetrahedron, 1972, 28, 2341–2352.
M. P. Cava and B. Weinstein, Chem. Ind. (London), The Structure of Andrographolide 1959, 851.
M. P. Cava, W. R. Chan, L. J. Haynes, L. F. Johnson and B. Weinstein, The Structure of Andrographolide, Tetrahedron, 1962, 18, 397–403.
I. Kitagawa, K. Hine, T. Nishimura, E. Mukai, I. Yosioka, H. Inouye, and T. Yoshida, Picroside I: A New Bitter Principle of Picrorhiza kurooa (Scrophulariaceae), Tetrahedron Lett., 1969, 3837–3840.
Dictionary of Organic Compounds, Ed. Buckingham, Chapman and Hall, London, 5th edn., 7th Supplement, 1989, p. 88.
F. M. Dean, Naturally Occurring Coumarins, Fortschr. Chem. Org. Naturstoffe, 1952, 9, 226–291.
Leonard R. Worden, Kurt Dunn Kaufman, James A. Weis and Thomas K. Schaaf, Synthetic Furocoumarins, IX. New Synthetic Route to Psoralen, J. Org. Chem., 1969, 34, 2311.
G. Mehta, U. R. Nayak nd Sukh Dev, Meroterpenoids - I Psoralea corylifolia Linn.-1. Bakuchiol, A Novel Monoterpene Phenol, Tetrahedron, 1973, 29, 1119–1125.
A. S. C. Prakasa Rao, V. K. Bhalla, U. R. Nayak, and Sukh Dev, Monoterpenoids – II Psoralea corylifolia Linn. – 2. Absolute Configuration of (+)-Bakuchiol, Tetrahedron, 1973, 29, 1127–1130.
N. P. Damodaran and Sukh Dev, Meroterpenoids – III Psoralea corylifolia Linn. – 3. Synthesis of (±)-Bakuchiol Methyl Ether, Tetrahedron, 1973, 29, 1209–1213.
Dictionary of Organic Compounds, Ed. Buckingham, Chapman and Hall, London, 1982, Vol. 4, 5th edn., p. 4475.
S. MacKinnon, T. Durst, J. T. Arnason, C. Angerhofer, J. Pezzuto, P. E. Sanchez-Vindas and L. J. Poveda, Antimalarial Activity of Tropical Meliaceae Extracts and Gedunin Derivatives, J. Nat. Prod., 1997, 60, 336–341.
Sami A. Khalid, Helmut Duddeck, and Manuel Gonzalez-Sierra, Isolation and Characterization of an Antimalarial Agent of the Neem Tree Azadirachta indica, J. Nat. Prod., 1989, 52, 922–927.
Thomas Nogrady and Donald F. Weaver, Medicinal Chemistry (A Molecular and Biochemical Approach), Oxford University Press, 2005.
Richard B. Silverman, The Organic Chemistry of Drug Design and Drug Action, Second Edition, Elsevier, 2004, p 280.
Mary Kamienski and Jim Keogh, Pharmacology McGraw-Hill, New York, New Delhi 2006.
Theodore M. Brody, Joseph Larner, Kenneth P. Minneman and Harold C. Neu, Human Pharmacology, Second Edition, Mosby, London, New York, Tokyo, 1995.
Graham L. Patrick, An Introduction to Medicinal Chemistry, Oxford University Press, Indian Edition, 2009.
Leon Shargel, Susanna Wu-pong, and Andrew B. C. Yu, Applied Biopharmaceutics & Pharmacokinetics, McGraw Hill, 5th Edn. Boston, 2005, Chapter7, pp161-184.
Malcolm Rawland and Thomas N. Tozer, Clinical Pharmacokinetics and Pharmacodynamics: Concepts and Applications, Wolter Kluwer/Lippincott Williams& Wilkins 4th Edn., Chapter 8, pp 217–244; Chapter 9, pp 245–258.
Sophie Jourdier, A Miracle Drug, Chem. Brit,1999, February Issue, 33–35, and references cited.
K. C. Nicolaou and T. Montagnon, Molecules That Changed the World, Wiley-VCH, 2008, pp. 20–28.
Sir R. N. Chopra, I. C. Chopra, K. L. Handa, L. D. Kapur, Indigenous Drugs of India, Academic Publishers, Kolkata, 2nd edition, 3rd reprint, 2006, p. 179.
John R. Vane, Inhibition of Prostaglandin Synthesis as a Mechanism of Action for Aspirin-like Drugs, Nature (New Biol.), 1971, 231, 232–235.
David L. DeWitt, E. A. El-Harith, Stacey A. Kraemer, Martha J. Andrews, Eveline F. Yao, Robert. L. Armstrong, and William L. Smith, The Aspirin and Heme-binding Sites of Ovine and Murine Prostaglandin Endoperoxide Synthases, J. Biol. Chem., 1990, 265, 5192–5198.
G. Phillip Hochgesang, Jr., Scott W. Rowlinson, and Lawrence J. Marnett, Tyrosine-385 is Critical for Acetylation of Cyclooxygenase-2 by Aspirin, J. Am. Chem. Soc. , 2000, 122, 6514–6515.
Gerald J. Roth, Nancy Stanford, and Philip W. Majerus, Acetylation of Prostaglandin Synthase by Aspirin, Proc. Nat. Acad. Sci., USA, 1975, 72, 3073–3076.
L. S. Goodman and A. Gilman, The Pharmacological Basis of Therapeutics, 4th ed., Collier-Macmillan, London, 1970.
Antony R. Butler and Yu-Lin-Wu, Artemisinin (Qinghaosu): A New Type of Antimalerial Drug, Chem. Soc. Rev., 1992, 85–90.
Resistance Resistant Drug, Research, Chemistry World, May 2013, 10, 26.
John Weisner, Regina Ortmann, Hassan Vomma, and Martin Schlitzar, New Antimalarial Drugs, Angew. Chem. Int. Ed., 2003, 42, 5274–5293.
Yuxiang Dong, and 19 co-authors, The Structure –Activity Relationship of the Antimalarial Ozonide Arterolane (OZ277), J. Med. Chem., 2010, 53, 481–491.
S. Heinhorst and C. G. Cannon, Environmental Problems and New Hope for the Treatment of Malaria, J. Chem. Educ., 2005, 62, 186–188.
Jonathan L. Vennerstron, and 18 co-authors, Identification of an Antimalarial Synthetic Trioxolane Drug Development Candidate, Nature, 2004, 430, 900–904.
Isabelle Weissbuch and Leslie Leiserowitz, Interplay between Malaria, Crystalline Hemozoin Fornation, and Antimalarial Drug Action and Design, Chem. Rev., 2008, 108, 4899–4914, and references 7–10 cited therein.
Petr Dzubak, Marian Hajduch, David Vydra, Alica Hustova, Miroslav Kvasnica, David Biedermann, Lenka Markova, Milan Urban, and Jan Sarek, Pharmacological Activities of Natural Triterpenoids and Their Therapeutic Implications, Nat. Prod. Rep., 2006, 23, 394–411.
K. C. Nicolaou and S. A. Snyder, Vinblastine in Classics in Total Synthesis. II, Wiley VCH, Weinheim, 2003, pp. 505–530.
Paul Jenkins, Taxol Branches Out, Chem. Brit., 1996, November issue, pp. 43–46.
Monroe E. Wall, Camptothecin and Taxol: Discovery to Clinic, Med. Res. Rev., 1998, 18, 299–314.
W. A. Denny, Deoxyribonucleic Acid Topoisomerase in Comprehensive Medicinal Chemistry II, Editors-in-Chief: John B. Taylor & David J. Triggle, Volume Editors: Jacob J. Plattner & Monoj C. Desai, Vol 7, 2007, Elsevier, pp 111–127.
Gordon M. Cragg, Paclitaxel (Taxol): A Success Story with Valuable Lessions for Natural Product drug Discovery and Development, Med. Res. Rev., 1998, 18, 315–331.
David G. I. Kingston, The Shape of Things to Come: Structural and Synthetic Studies of Taxol and Related Compounds, Phytochemistry, 2007, 68, 1844–1854. (A review on the history of the development of taxol as an anticancer drug)
Scott A. Johnson, Ana A. Alcaraz, and James P. Snyder, T-Taxol and the Electron Crystallographic Density in β-Tubulin, Organic Letters, 2005, 7, 5549–5552.
Richard B. Silverman, The Organic Chemistry of Drug Design and Drug Action, Second Edition, Elsevier, 2004. p. 23 (Fig. 2.2)
Mimin Wang, Ben Cornett, Jim Nettles, Dennis C. Liotta, and James P. Snyder, The Oxetane Ring in Taxol, J. Org. Chem., 2000, 65, 1059–1068, and references cited.
Francoise Gueritte-Voegelein, Daniel Guenard, Francois Lavelle, Marie-Therese Le Goff, Lydie Mangatal, and Pierre Potier, Relationships between the Structure of Taxol Analogues and Their Antimitotic Activity, J. Med. Chem., 1991, 34, 992–998.
Mark S. Butler, Natural Products to Drugs. Natural Product Derived Compounds in Clinical Trials, Nat. Prod. Rep., 2005, 22, 162–195.
Ramesh C. Pandey, Prospecting for Potentially New Pharmaceuticals from Natural Sources, Med. Res. Rev., 1998, 18, 333–346.
G. Chakraborty, S. Sengupta and B. Bhattacharyya, Thermodynamics of Colchinoid-Tubulin Interactions- Role of B Ring and C7 Substituent, J. Biol. Chem., 1996, 271, 2897–2901.
Dulal Panda, Janet E. Daijo, Mary Ann Jordan and Leslie Wilson, Kinetic Stabilization of Microtubule Dynamics at Steady State in vitro by Substoichiometric Concentrations of Tubulin-Colchicine Complex, Biochemistry, 1995, 34, 9921–9929.
T. N. Margulis, Structure of the Miotic Spindle Inhibitor Colcemid, N-Desacetyl-N-Methylcolchicine, J. Am. Chem. Soc., 1974, 96, 899
Hans-Walter Heldt, ‘Plant Biochemistry’, Third Edition, 2005, Elsevier, First Printed in India 2005, p. 492.
R. N. Chopra, I. C. Chopra, K. L. Handa and L. D. Kapur, ‘Indigenous Drugs of India’, Academic Publishers, Kolkata, Third Print 2006, p. 8. pp. 397–401.
Thomas Nogrady and Donald F. Weaver, Medicinal Chemistry (A Molecular and Biochemical Approach), Oxford University, 2005, p. 226.
For agonist and antagonist terminology see Theodore M. Brody, Joseph Larner, Kenneth P. Minneman and Harold C. New, Human Pharmacology, Second Edition, 1994, Mosby, Boston, Tokyo, Toronto, Chapter 2 (p. 9–23) and Chapter 3 (p. 25–32).
Marshall Gates, Analgesic Drugs, Scientific American, 1966, 131–137, pertinent page 132–133.
Mark S. Butler, Natural Products to Drugs : Natural Product Derived Compounds in Clinical Trails, Nat. Prod. Rep., 2005, 22, 162–195.
Guo-wei Qin and Ren-Sheng Xu, Recent Advances on Bioactive Natural Products from Chinese Medicinal Plants, Med. Res. Revs., 1998, 18, 375–382.
Goutam Brahmachari, Natural Products in the Drug Discovery Programmes in Alzheimer’s: Impacts and Progress, Asia Pacific Biotech. News, Singapore, 2011, 15, (Sept. issue), p. 26–38.
Thomas Nogrady and Donald F. Weaver, Medicinal Chemistry, A Molecular and Biochemical Approach, Oxford University Press, 2005, p. 292–295.
T. Motai, A. Dakonya and S. Kitanaka, Sesquiterpene Coumarins from Ferula fukanensis and Nitric Oxide production Inhibitory Effects, J. Nat. Prod., 2004, 67, 432–436.
K. K. Jung, H. S. Lee, J. Y. Cho, W. C. Shin, M. H. Rhee, T. G. Kim, J. H. Kang, S. H. Kim, S. Hong and S. Y. Kang, Inhibitory Effect of Curcumin on Nitric Oxide Production from Lipapolysaccharide-Activated Primary Microglia, Life Sci., 2006, 79, 2022–2031.
DeFatima and Madolo, Natural Products as NOS Inhibitors in Natural Products Chemistry, Biochemistry and Pharmacology, Ed. Gautam Brahmachari, 2009, Chapter 2, pp. 21–53.
Michael A. Palladino, Frances Rena Bahjat, Emmanuel A. Theodorakis and Lyle L. Moldawar, Anti TNT-α Therapies : The Next Generation, Drug Discovery, 2003, 2, 736–746 pertinent pp. 742–743.
R. N. Chopra, I. C. Chopra, K. L. Handa and L. D. Kapur, ‘Indigenous Drugs of India’, Academic Publishers, Kolkata, Third Print 2006, p 61–63.
Peter Atherton, First Aid Plant, Chem. Brit., May Issue, 1998, 33–36.
Sunil K.. Talapatra, Asok K. Mallik, and Bani Talapatra, A New Hydroxyfuranoflavone and Aurantiamide Acetate, A Dipeptide from the Flowers of Pongamia glabra, Phytochemistry,1980, 19, 1199–1202.
Sunil K. Talapatra, Asok K. Mallik, and Bani Talapatra, Isopongaglabol and 6-Methoxyisopongaglabol, Two New Hydroxyfuranoflavones from Pongamia glabra, Phytochemistry, 1982, 21, 761–766.
An Ullmann’s Encyclopedia, Industrial Organic Chemistry, Vol.8, Wiley-VCH, New York, 1999.
© 2015 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Talapatra, S.K., Talapatra, B. (2015). Natural Products in the Parlor of Pharmaceuticals. In: Chemistry of Plant Natural Products. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-45410-3_33
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-45409-7
Online ISBN: 978-3-642-45410-3